Cobimetinib

Cobimetinib

SCHEMBL29413464

Cl.O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1

nearest known ligand 0.98

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

MAP2K1MAP2K2

The experimentally established mechanism targets of Cobimetinib. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
MAP2K1 known ✓ Q02750 20/20 0.98
MAP2K2 known ✓ P36507 19/20 0.98
CHRM2 P08172 1/20 0.98
CHRM1 P11229 1/20 0.98
BRAF P15056 1/20 0.98
DRD1 P21728 1/20 0.98
TBXA2R P21731 1/20 0.98
SLC6A2 P23975 1/20 0.98
SLC6A4 P31645 1/20 0.98
ADRA1A P35348 1/20 0.98
OPRM1 P35372 1/20 0.98
DRD3 P35462 1/20 0.98
ACTR3 P61158 1/20 0.98
SLC6A3 Q01959 1/20 0.98
KCNH2 Q12809 1/20 0.98

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Cobimetinib SCHEMBL1488436 1.00 MAP2K1 (0.98) MAP2K1MAP2K2CHRM2CHRM1BRAF
Cobimetinib SCHEMBL1489148 1.00 MAP2K1 (0.98) MAP2K1MAP2K2CHRM2CHRM1BRAF
Cobimetinib SCHEMBL30220897 1.00 MAP2K1 (0.98) MAP2K1MAP2K2CHRM2CHRM1BRAF
Cobimetinib SCHEMBL29413366 0.99 MAP2K1 (1.00) MAP2K1MAP2K2CHRM2CHRM1BRAF
Cobimetinib SCHEMBL1488831 0.99 MAP2K1 (1.00) MAP2K1MAP2K2CHRM2CHRM1BRAF
Cobimetinib SCHEMBL29839406 0.99 MAP2K1 (1.00) MAP2K1MAP2K2CHRM2CHRM1BRAF
Cobimetinib SCHEMBL189565 0.99 MAP2K1 (1.00) MAP2K1MAP2K2CHRM2CHRM1BRAF
Cobimetinib SCHEMBL188704 0.99 MAP2K1 (1.00) MAP2K1MAP2K2CHRM2CHRM1BRAF
Cobimetinib SCHEMBL29358284 0.99 MAP2K1 (1.00) MAP2K1MAP2K2CHRM2CHRM1BRAF
SCHEMBL189480 0.96 MAP2K1 (0.95) MAP2K1MAP2K2CHRM2CHRM1BRAF

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109053523-B Azetidines as MEK inhibitors for the treatment of proliferative diseases 埃克塞利希斯股份有限公司 2022-03-25 CN disclosed